| Machine learning applications in the diagnosis of leukemia: Current trends and future directions HT Salah, IN Muhsen, ME Salama, T Owaidah, SK Hashmi International journal of laboratory hematology 41 (6), 717-725, 2019 | 119 | 2019 |
| Genotypic and phenotypic characteristics of acute promyelocytic leukemia translocation variants A Mannan, IN Muhsen, E Barragán, MA Sanz, M Mohty, SK Hashmi, ... Hematology/Oncology and Stem Cell Therapy 13 (4), 189-201, 2020 | 39 | 2020 |
| Artificial intelligence approaches in hematopoietic cell transplantation: a review of the current status and future directions IN Muhsen, T Elhassan, SK Hashmi Turkish Journal of Hematology 35 (3), 152, 2018 | 31 | 2018 |
| Long-term follow-up for the development of subsequent malignancies in patients treated with genetically modified IECs DHM Steffin, IN Muhsen, LQC Hill, CA Ramos, N Ahmed, M Hegde, ... Blood, The Journal of the American Society of Hematology 140 (1), 16-24, 2022 | 28 | 2022 |
| Hepatitis B virus reactivation in cancer patients treated with immune checkpoint inhibitors EA Burns, IN Muhsen, K Anand, J Xu, G Umoru, AN Arain, M Abdelrahim Journal of Immunotherapy 44 (3), 132-139, 2021 | 26 | 2021 |
| Current status and future perspectives on the Internet of Things in oncology IN Muhsen, OW Rasheed, EA Habib, RK Alsaad, MK Maghrabi, ... Hematology/oncology and stem cell therapy 16 (2), 102-109, 2023 | 23 | 2023 |
| Recent advances in diagnosis and therapy of angioimmunoblastic T cell lymphoma MF Mohammed Saleh, A Kotb, GEM Abdallah, IN Muhsen, R El Fakih, ... Current Oncology 28 (6), 5480-5498, 2021 | 23 | 2021 |
| Bone mineral density loss in patients with cirrhosis IN Muhsen, O AlFreihi, F Abaalkhail, A AlKhenizan, M Khan, A Eldali, ... Saudi Journal of Gastroenterology 24 (6), 342-347, 2018 | 22 | 2018 |
| Recent trends and advancements in the diagnosis and management of gastric cancer E Haque, A Esmail, I Muhsen, H Salah, M Abdelrahim Cancers 14 (22), 5615, 2022 | 19 | 2022 |
| Machine learning applications in the diagnosis of benign and malignant hematological diseases IN Muhsen, D Shyr, AD Sung, SK Hashmi Clinical Hematology International 3 (1), 13-20, 2021 | 19 | 2021 |
| Cardiovascular risks with epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors and monoclonal antibody therapy KR Chitturi, EA Burns, IN Muhsen, K Anand, BH Trachtenberg Current oncology reports 24 (4), 475-491, 2022 | 16 | 2022 |
| Free of malignancy but not of fears: a closer look at Damocles syndrome in survivors of hematologic malignancies MS Alabdaljabar, IN Muhsen, JM Knight, KL Syrjala, SK Hashmi Blood reviews 48, 100783, 2021 | 15 | 2021 |
| Endemic or regionally limited parasitic and fungal infections in haematopoietic stem-cell transplantation recipients: a Worldwide Network for Blood and Marrow Transplantation … IN Muhsen, S Galeano, D Niederwieser, MBC Koh, P Ljungman, ... The Lancet Haematology 10 (4), e295-e305, 2023 | 11 | 2023 |
| Clinical, diagnostic and prognostic characteristics of primary cutaneous gamma delta T-cell lymphomas IN Muhsen, R El Fakih, M Hamadani, HM Lazarus, MA Kharfan-Dabaja, ... Clinical Hematology International 4 (1), 1-10, 2022 | 10 | 2022 |
| Follow-up issues in survivors of hematologic malignancies–Current stance and future perspectives IN Muhsen, M Bar, BN Savani, EH Estey, SK Hashmi Blood reviews 44, 100674, 2020 | 9 | 2020 |
| Registries and artificial intelligence: investing in the future of hematopoietic cell transplantation IN Muhsen, M Jagasia, AA Toor, SK Hashmi Bone Marrow Transplantation 54 (3), 477-480, 2019 | 7 | 2019 |
| Endemic or regionally limited bacterial and viral infections in haematopoietic stem-cell transplantation recipients: a Worldwide Network for Blood and Marrow Transplantation … IN Muhsen, S Galeano, D Niederwieser, MBC Koh, P Ljungman, ... The Lancet Haematology 10 (4), e284-e294, 2023 | 6 | 2023 |
| Infectious complications and preventative strategies following chimeric antigen receptor T-cells (CAR-T cells) therapy for B-cell malignancies A Haroon, IN Muhsen, MB Abid, A Albabtain, A Alahmari, SO Ahmed, ... Hematology/Oncology and Stem Cell Therapy 15 (3), 153-158, 2022 | 6 | 2022 |
| Chemoresistance in uterine cancer: Mechanisms of resistance and current therapies A Arain, IN Muhsen, A Abudayyeh, M Abdelrahim Overcoming drug resistance in gynecologic cancers, 267-281, 2021 | 6 | 2021 |
| Bortezomib for immune thrombocytopenia and autoimmune hemolytic anemia IN Muhsen, A Alahmari, M Alnahedh, NA Alkhudair, H Samarkandi, ... Hematol Oncol Stem Cell Ther 13 (4), 251-4, 2020 | 6 | 2020 |
Shahrukh HashmiMayo Clinic / SSMC在 mayo.edu 的电子邮件经过验证
